Clinical Trial Update: Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma [Phase 2]

View source ↗

Summary

Phase II clinical trial update for everolimus in children and adolescents with refractory or relapsed osteosarcoma; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Sidnei Epelman | Conditions: Refractory or Relapsed Osteosarcoma | Phase 2 | Status: UNKNOWN